SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

N9 - Neuroscience in the Clinic: Afferent and Efferent Visual Pathway Manifestations of Neurodegenerative Diseases: Implications for Diagnosis and Treatment

Event Time: Friday April 28, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders, Neuro-ophthalmology/Neuro-otology
Director(s): Heather Moss MD, PhD, FAAN, Gregory Van Stavern MD, FAAN
Description: Neurodegenerative diseases, particularly dementing disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), are increasing in prevalence, related in part to the aging of the population. Visual dysfunction is an under-recognized and important cause of overall neurologic disability and reduced quality of life in neurodegenerative diseases. This program will review visual dysfunction (including the afferent and efferent systems as well as the cognitive visual manifestations of disease) in several neurodegenerative disorders, with special focus on clinical neuro-ophthalmic testing and vision disability in AD and PD and other neurodegenerative conditions. This will be achieved with faculty presentations on clinical aspects, scientific aspects and abstract presentations. The aim is to increase recognition of the types of visual dysfunction that occur in association with neuro-degenerative diseases, as well as the causes, impact on quality of life, and the steps in evaluation and treatment in patients who experience these symptoms.
Completion Message: Participants should be familiar with patterns of afferent and efferent visual dysfunction in patients with neuro-degenerative disease, understand an approach to diagnosis and treatment of resulting visual symptoms and get an update on new break-throughs in the field.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Systems-Based Practice

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:05 PM Introduction Heather Moss MD, PhD, FAAN 
1:05 PM - 1:10 PM Case: Afferent Visual Dysfunction Faculty 
1:10 PM - 1:20 PM Clinical Aspects of Afferent Visual Dysfunction in Neuro-degenerative Diseases Victoria Pelak MD 
1:20 PM - 1:35 PM Scientific Aspects of Afferent Visual Dysfunction in Neuro-degenerative Disease Geoffrey Aguirre MD, PhD 
1:35 PM - 1:45 PM N9.001: Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults Michael Ward MD, PhD 
1:45 PM - 1:50 PM Case: Efferent Visual Dysfunction Faculty 
1:50 PM - 2:00 PM Clinical Aspects of Efferent Visual Dysfunction in Neuro-degenerative Diseases Matthew Thurtell MD 
2:00 PM - 2:15 PM Eye Movement and Reading Abnormalities in Parkinsonism Y. Joyce Liao MD, PhD 
2:15 PM - 2:25 PM N9.002: What are the phenotypes of Brazilian patients with autossomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)?: Neurological, ophthalmological and neuroimaging features of seven genetically confirmed cases Flavio Rezende Filho  
2:25 PM - 2:35 PM The Visual System as a Biomarker for Neuro-degenerative Diseases Gregory Van Stavern MD, FAAN 
2:35 PM - 3:00 PM Panel Discussion Faculty 

Disclosures

Speaker Disclosure
Geoffrey Karl Aguirre, MD, PhD Dr. Aguirre has nothing to disclose.

Y. Joyce Liao, MD, PhD Dr. Liao has nothing to disclose.

Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with legal firms.

Victoria S. Pelak, MD Dr. Pelak has received personal compensation in an editorial capacity for Up-to-Date, Inc.

Flavio Rezende Filho Dr. Rezende Filho has nothing to disclose.

Matthew J. Thurtell, MD Co-investigator on NIH-funded research..

Gregory P. Van Stavern, MD, FAAN Dr. Van Stavern has nothing to disclose.

Michael Ward, MD, PhD Dr. Ward has nothing to disclose.

Abstract Presenters

Start Time Pub. Title Presenter
1:35 PM 001 Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults Michael Ward, MD, PhD
Disclosure:
Dr. Ward has nothing to disclose.

2:15 PM 002 What are the phenotypes of Brazilian patients with autossomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)?: Neurological, ophthalmological and neuroimaging features of seven genetically confirmed cases. Flavio Rezende Filho
Disclosure:
Dr. Rezende Filho has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C3 Emergency Room Neuro-ophthalmology Heather Moss MD, PhD, FAAN
C4 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
9:30 AM-11:30 AM
C14 Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
1:30 PM-3:30 PM
C18 Pediatric Neuro-ophthalmology Update Christopher Glisson DO
C23 Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C24 Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C25 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema Nancy Newman MD, FAAN
1:00 PM-3:00 PM
C36 Nonmotor Manifestations of Parkinson's Disease I Charles Adler MD, PhD, FAAN
C43 Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria Nancy Newman MD, FAAN
3:30 PM-5:30 PM
C50 Nonmotor Manifestations of Parkinson's Disease II Charles Adler MD, PhD, FAAN
C56 Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Nancy Newman MD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C60 Neuro-ophthalmology: Overview and Update Nancy Newman MD, FAAN
C65 Video EEG: Name That Spell Amy Crepeau MD
C58 Balance and Gait Disorders Bastiaan Bloem MD, PhD
1:00 PM-3:00 PM
C67 Evaluating Tremor in the Office Vicki Shanker MD
1:00 PM-5:30 PM
C83 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop John Pula MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C140 Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C133 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
1:00 PM-3:00 PM
C152 Nystagmus and Saccadic Intrusions Made Simple Janet Rucker MD
1:00 PM-5:30 PM
C159 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop Diego Torres-Russotto MD, FAAN
3:30 PM-5:30 PM
C167 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Janet Rucker MD

Thursday April 26, 2018

7:00 AM-9:00 AM
C176 The Dystonia: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
1:00 PM-3:00 PM
C187 Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
C191 Neuro-otology I: The Common Peripheral Vestibular Disorders Kevin Kerber MD
3:30 PM-5:30 PM
C205 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness Kevin Kerber MD
C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop Allison Brashear MD, MBA, FAAN
6:30 PM-9:30 PM
C213 Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

MEMBER LOG IN

Forgot Password?